DK1334720T3 - Nateglinid-indeholdende fremstillinger - Google Patents

Nateglinid-indeholdende fremstillinger

Info

Publication number
DK1334720T3
DK1334720T3 DK01976817T DK01976817T DK1334720T3 DK 1334720 T3 DK1334720 T3 DK 1334720T3 DK 01976817 T DK01976817 T DK 01976817T DK 01976817 T DK01976817 T DK 01976817T DK 1334720 T3 DK1334720 T3 DK 1334720T3
Authority
DK
Denmark
Prior art keywords
nateglinide
containing preparations
antidiabetic
immediate
amorphous
Prior art date
Application number
DK01976817T
Other languages
English (en)
Inventor
N Ninomiya
Chisato Makino
Akira Yabuki
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of DK1334720T3 publication Critical patent/DK1334720T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01976817T 2000-10-24 2001-10-23 Nateglinid-indeholdende fremstillinger DK1334720T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000324373 2000-10-24
PCT/JP2001/009291 WO2002034254A1 (fr) 2000-10-24 2001-10-23 Preparations contenant du nateglinide

Publications (1)

Publication Number Publication Date
DK1334720T3 true DK1334720T3 (da) 2009-01-19

Family

ID=18801918

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01976817T DK1334720T3 (da) 2000-10-24 2001-10-23 Nateglinid-indeholdende fremstillinger

Country Status (17)

Country Link
US (2) US7605180B2 (da)
EP (1) EP1334720B1 (da)
JP (3) JP4501054B2 (da)
KR (1) KR100869039B1 (da)
CN (1) CN100352432C (da)
AT (1) ATE406885T1 (da)
AU (1) AU2001295999A1 (da)
BR (1) BR0114896A (da)
CA (1) CA2426263C (da)
DE (1) DE60135674D1 (da)
DK (1) DK1334720T3 (da)
ES (1) ES2307653T3 (da)
MX (1) MXPA03003685A (da)
PT (1) PT1334720E (da)
RU (1) RU2271805C2 (da)
TW (1) TWI283573B (da)
WO (1) WO2002034254A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20022294A3 (cs) * 1999-12-28 2002-11-13 Ajinomoto Co., Inc. Antidiabetický preparát k orálnímu uľití
KR20070104953A (ko) * 2000-03-17 2007-10-29 아지노모토 가부시키가이샤 신경 장애용 약제
CA2425538C (en) * 2000-10-18 2010-10-12 Ajinomoto Co., Inc. Methods for producing nateglinide crystals
PT1334962E (pt) * 2000-10-18 2007-10-09 Ajinomoto Kk ''processo de preparação de acilfenilalaninas''
RU2271805C2 (ru) * 2000-10-24 2006-03-20 Адзиномото Ко., Инк. Препарат, содержащий натеглинид
CA2426745C (en) * 2000-10-24 2009-09-15 Ajinomoto Co., Inc. Methods for producing nateglinide b-type crystals
ATE429217T1 (de) * 2000-10-24 2009-05-15 Ajinomoto Kk Nateglinid enthaltende hydrophile arzneimittelpräparate
JP4833464B2 (ja) * 2001-11-28 2011-12-07 大正製薬株式会社 難溶性薬物含有固形製剤の製造方法
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
US7420084B2 (en) 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
KR100882156B1 (ko) * 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2005020979A1 (en) * 2003-09-03 2005-03-10 Ranbaxy Laboratories Limited A process for the preparation of pharmaceutical compositions of nateglinide
US20070219250A1 (en) * 2003-11-28 2007-09-20 Romi Singh Pharmaceutical Compositions of Nateglinide
WO2005094812A1 (ja) * 2004-04-01 2005-10-13 Ajinomoto Co., Inc. ナテグリニド含有製剤
WO2006016602A1 (ja) * 2004-08-10 2006-02-16 Ajinomoto Co., Inc. 苦味の低減したナテグリニド含有製剤
EP1891971A4 (en) * 2005-01-31 2010-02-03 Ajinomoto Kk MEDICAL COMPOSITION USING HYPERGLY CRAB MEDICAMENT TO TREAT OR TREAT GLUCOSE-INTOLERANCE, BORDERLINE DIABETES, INSULIN RESISTANCE AND HYPERINSULINEMIA
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
SG179497A1 (en) 2007-03-29 2012-04-27 Daiichi Sankyo Co Ltd Pharmaceutical composition
TR200801178A2 (tr) * 2008-02-22 2009-09-23 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları
CN101590063A (zh) * 2008-05-26 2009-12-02 中国科学院上海生命科学研究院 丹参酮iia在制备治疗肥胖及胰岛素抵抗的药物中的应用
WO2011115067A1 (ja) 2010-03-19 2011-09-22 第一三共株式会社 抗凝固剤の溶出改善方法
AU2011266820A1 (en) 2010-06-14 2013-01-24 Cipla Limited A process for the preparation of nateglinide
ES2673182T3 (es) 2011-08-10 2018-06-20 Daiichi Sankyo Company, Limited Composición farmacéutica que contiene un derivado de diamina
CN102813636B (zh) * 2012-08-28 2014-04-16 西南药业股份有限公司 那格列奈片及其制备方法
CA2918570A1 (en) * 2013-07-22 2015-01-29 Sandoz Ag Formulations containing amorphous dapagliflozin
ES3063790T3 (en) 2015-06-09 2026-04-20 Lonza Sales Ag Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
JP6647902B2 (ja) * 2015-10-30 2020-02-14 株式会社ファンケル 徐放性顆粒剤
KR20240025990A (ko) * 2022-08-19 2024-02-27 주식회사 스카이테라퓨틱스 무정형 수니티닙, 그 제조방법 및 이를 포함한 의약 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
JPH0249720A (ja) * 1988-05-18 1990-02-20 Mitsubishi Kasei Corp 難溶性薬剤組成物
US5041232A (en) * 1990-03-16 1991-08-20 Lever Brothers Company, Division Of Conopco, Inc. Sulfonimines as bleach catalysts
JPH0415221A (ja) 1990-05-08 1992-01-20 Daicel Chem Ind Ltd ポリカーボネートの製造法
US5232735A (en) * 1990-06-01 1993-08-03 Bioresearch, Inc. Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
DE10199058I2 (de) * 1991-07-30 2006-04-27 Alcm Co Kristalle von N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanin und Verfahren zu ihrer Herstellung
AU718350B2 (en) * 1996-11-15 2000-04-13 Ajinomoto Co., Inc. Tablet composition
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
EP1049459B1 (en) * 1998-01-20 2009-04-22 Applied Analytical Industries, Inc. Oral liquid compositions
US6559188B1 (en) * 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
CZ20022294A3 (cs) 1999-12-28 2002-11-13 Ajinomoto Co., Inc. Antidiabetický preparát k orálnímu uľití
KR20070104953A (ko) 2000-03-17 2007-10-29 아지노모토 가부시키가이샤 신경 장애용 약제
CA2425538C (en) 2000-10-18 2010-10-12 Ajinomoto Co., Inc. Methods for producing nateglinide crystals
PT1334962E (pt) 2000-10-18 2007-10-09 Ajinomoto Kk ''processo de preparação de acilfenilalaninas''
ATE429217T1 (de) 2000-10-24 2009-05-15 Ajinomoto Kk Nateglinid enthaltende hydrophile arzneimittelpräparate
RU2271805C2 (ru) * 2000-10-24 2006-03-20 Адзиномото Ко., Инк. Препарат, содержащий натеглинид
CA2426745C (en) 2000-10-24 2009-09-15 Ajinomoto Co., Inc. Methods for producing nateglinide b-type crystals
US6830759B2 (en) 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
KR100882156B1 (ko) * 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제

Also Published As

Publication number Publication date
CA2426263C (en) 2010-05-25
JP2013028636A (ja) 2013-02-07
US7605180B2 (en) 2009-10-20
CN100352432C (zh) 2007-12-05
JPWO2002034254A1 (ja) 2004-08-26
AU2001295999A1 (en) 2002-05-06
EP1334720B1 (en) 2008-09-03
BR0114896A (pt) 2003-08-12
TWI283573B (en) 2007-07-11
KR100869039B1 (ko) 2008-11-17
PT1334720E (pt) 2008-09-30
KR20030042027A (ko) 2003-05-27
CN1482903A (zh) 2004-03-17
WO2002034254A1 (fr) 2002-05-02
JP5610165B2 (ja) 2014-10-22
EP1334720A4 (en) 2004-02-04
EP1334720A1 (en) 2003-08-13
MXPA03003685A (es) 2004-01-26
DE60135674D1 (de) 2008-10-16
US20090203791A1 (en) 2009-08-13
ATE406885T1 (de) 2008-09-15
RU2271805C2 (ru) 2006-03-20
JP2010100654A (ja) 2010-05-06
ES2307653T3 (es) 2008-12-01
US20040014815A1 (en) 2004-01-22
JP4501054B2 (ja) 2010-07-14
CA2426263A1 (en) 2003-04-23

Similar Documents

Publication Publication Date Title
DK1334720T3 (da) Nateglinid-indeholdende fremstillinger
NZ527032A (en) Isoxazoline derivative and herbicide containing the same as the active ingredient
NO20034149L (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
NO20016107L (no) Mesalazin-kontrollert frigivelse orale farmasöytiske sammensetninger
DK1300398T3 (da) Propan-1,3-dionderivat
USD456051S1 (en) Exercise device
DE60210784D1 (de) Orale antidiabetische wirkstoffe
USD469180S1 (en) Elongated applicator handle having a distributor at both ends
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
DK1389213T3 (da) 3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser
ITMI20000440A0 (it) Forme solide orali a rilascio controllato contenenti mesalazina come principio attivo
USD457990S1 (en) Animal toy ring
DE50212634D1 (de) Agrochemische formulierungen
ZA200304928B (en) Medicament containing a polyamine as an active substance.
ATE365734T1 (de) Herbizide furanyl- und thienyloxyazine
ITMI20001848A0 (it) Faramaci per l'incontinenza.
RU2000118409A (ru) Антимутагенное средство
NO20041878D0 (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
EP0729950A4 (en) ANTI-HIV MEDICINAL PRODUCTS
Fitzerald Guilty until proven innocent
ITMI20000972A0 (it) Formulazioni farmaceutiche, a rilascio modificato, con elevata biodisponibilita', contenenti principi attivi ad attivita' antibiotica.
AU2002306368A1 (en) Thiazolotriazole derivatives, intermediates thereof, and herbicides containing the derivatives as the active ingredient
AU2002224999A1 (en) Herbicidal active ingredient combinations
IT1318486B1 (it) Formulazione orale monodose ad uso veterirario.
AU2002235794B2 (en) Medicament containing a polyamine as an active substance